Long-term evaluation follow-up of neurocognitive performance and emotional state in patients with chronic hepatitis C infection and a former (Peg)interferon alfa-2b-based therapy
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Peginterferon alfa-2b (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics
- 13 Oct 2009 Actual patient number (197) added as reported by ClinicalTrials.gov.
- 13 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jul 2006 New trial record.